Article Details
Retrieved on: 2024-09-03 17:42:03
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Notably, an FDA-approved gene therapy product, onasemnogene abeparvovec (Zolgensma; Novartis), is available for the treatment of SMA. An adeno- ...
Article found on: www.cgtlive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here